Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers

scientific article published on 11 July 2016

Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S13300-016-0183-X
P8608Fatcat IDrelease_in6ux3hfcjepvi3g6bm3mz5uwi
P932PMC publication ID5014789
P698PubMed publication ID27402392

P2093author name stringWilliam Green
Matthew Taylor
P2860cites workBurden of diabetic foot ulcers for medicare and private insurers.Q51229127
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulinQ24203867
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyQ24652963
A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patientsQ26995462
Type 1 diabetesQ28301396
Hemoglobin A1c predicts healing rate in diabetic woundsQ35216266
Performance of an Electronic Diary System for Intensive Insulin Management in Global Diabetes Clinical TrialsQ35928254
Preventing foot ulcers in patients with diabetesQ36006260
Can a tool that automates insulin titration be a key to diabetes management?Q36131587
Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decadeQ36249607
A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers.Q36440640
Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic RegistryQ37278206
Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trialsQ37763986
Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.Q39624462
Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.Q40213395
Risk factors for recurrence of diabetic foot ulcers: prospective follow-up analysis in the Eurodiale subgroup.Q43587351
An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcersQ47793526
The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trialQ47889133
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P921main subjectcost-effectiveness analysisQ1754768
P304page(s)511-525
P577publication date2016-07-11
P1433published inDiabetes TherapyQ26853803
P1476titleCost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers
P478volume7

Reverse relations

cites work (P2860)
Q94468790Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: A systematic review
Q55116866Insulin therapy for type 2 diabetes - are we there yet? The d-Nav® story.